Robert Allison Franklin , MD

Bachelor of Arts: University of Georgia Atlanta, GA, 2008 (Philosophy, English Literature)

MD: University of Tennessee Health Science Center College of Medicine Memphis, TN, 2015 (Medicine)

Residency: University of Cincinnati Medical Center Cincinnati, Ohio, 2018 (Internal Medicine)

American Board of Internal Medicine (Certification Date: 08-24-2018 )

American Board of Internal Medicine (Hematology) (Certification Date: 11-30-2022 )

American Board of Internal Medicine (Medical Oncology) (Certification Date: 11-29-2022 )

Internal Medicine

Lung Cancer

Thoracic Cancer

Medical Oncology

N/A

Oncology

Bladder Cancer

Kidney Cancer

Penile Cancer

Prostate Cancer

Testicular Cancer

Internal Medicine

Hematology

Medical Oncology

Grant: #D9723C00001 Investigators:Franklin, Robert 04-08-2024 -04-08-2027 AstraZeneca Pharmaceuticals LP A Randomized, 2-cohort, Double-blind, Placebo-controlled, Phase III Study of AZD5305 in Combination with Physician's Choice New Hormonal Agents in Patients with HRRm and non-HRRm Metastatic Castration Role:PI 0.00 Hold Level:Industry

Clinical - University of Cincinnati Medical Center
234 Goodman St
Cincinnati  Ohio, 45219